UHRF1 and cancer: In addition, UHRF1 was downregulated to a greater extent in CD133+ cells compared with CD133− cells, indicating that UHRF1 deficiency may contribute to the maintenance of cancer stem-like cells (Supplementary Fig. S6b and c).